Has the MHRA approved the Wegovy pill?

Yes. The MHRA approved the Wegovy pill (oral semaglutide) for weight loss and weight management in the UK on 11 June 2026. It is the first GLP-1 tablet approved in the UK specifically for weight management. It may be prescribed alongside a reduced-calorie diet and increased physical activity for eligible adults with obesity, or those who are overweight with a weight-related health condition.

Key points:

  • The Wegovy pill has been approved by the MHRA in the UK.
  • It contains semaglutide, the same active ingredient used in Wegovy injections.
  • It is the first GLP-1 weight loss tablet approved in the UK.
  • It is expected to be available through private prescriptions before any potential NHS rollout.
  • NHS availability will depend on future NICE guidance and commissioning decisions.

This text has been fact-checked for accuracy by Alessandro Grenci, Superintendent Pharmacist at medino.